B. Leticia Rodriguez - Search Results

Year	Number of Results
2011	4
2012	4
2013	2
2014	2
2016	1
2018	1
2019	3
2020	4
2021	7
2022	3
2023	3
2024	1

1

Anti-tumor activity of a novel LAIR1 antagonist in combination with anti-PD-1 to treat collagen-rich solid tumors.

Rodriguez BL, Huang J, Gibson L, Fradette JJ, Chen HH, Koyano K, Cortez C, Li B, Ho C, Ashique AM, Lin VY, Crawley S, Roda JM, Chen P, Fan B, Kim J, Sissons J, Sitrin J, Kaplan DD, Gibbons DL, Rivera LB. Rodriguez BL, et al. Mol Cancer Ther. 2024 Apr 22. doi: 10.1158/1535-7163.MCT-23-0866. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38648067

2

Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti-PD-1 resistance in non-small cell lung cancer.

Konen JM, Rodriguez BL, Wu H, Fradette JJ, Gibson L, Diao L, Wang J, Schmidt S, Wistuba II, Zhang J, Gibbons DL. Konen JM, et al. Among authors: rodriguez bl. J Clin Invest. 2023 Sep 1;133(17):e163128. doi: 10.1172/JCI163128. J Clin Invest. 2023. PMID: 37655662 Free PMC article.

3

Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.

Rodriguez BL, Chen L, Li Y, Miao S, Peng DH, Fradette JJ, Diao L, Konen JM, Alvarez FRR, Solis LM, Yi X, Padhye A, Gibson LA, Ochieng JK, Zhou X, Wang J, Gibbons DL. Rodriguez BL, et al. Front Immunol. 2023 Jun 28;14:1161869. doi: 10.3389/fimmu.2023.1161869. eCollection 2023. Front Immunol. 2023. PMID: 37449205 Free PMC article.

4

ZEB1 Is Regulated by K811 Acetylation to Promote Stability, NuRD Complex Interactions, EMT, and NSCLC Metastasis.

Perez-Oquendo M, Manshouri R, Tian Y, Fradette JJ, Rodriguez BL, Kundu ST, Gibbons DL. Perez-Oquendo M, et al. Among authors: rodriguez bl. Mol Cancer Res. 2023 Aug 1;21(8):779-794. doi: 10.1158/1541-7786.MCR-22-0503. Mol Cancer Res. 2023. PMID: 37255406 Free PMC article.

5

Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasis.

Bajaj R, Rodriguez BL, Russell WK, Warner AN, Diao L, Wang J, Raso MG, Lu W, Khan K, Solis LS, Batra H, Tang X, Fradette JF, Kundu ST, Gibbons DL. Bajaj R, et al. Among authors: rodriguez bl. Cell Rep. 2022 Sep 27;40(13):111429. doi: 10.1016/j.celrep.2022.111429. Cell Rep. 2022. PMID: 36170810 Free PMC article.

6

The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8⁺ cytotoxic T-cell response.

Kundu ST, Rodriguez BL, Gibson LA, Warner AN, Perez MG, Bajaj R, Fradette JJ, Class CA, Solis LM, Rojas Alvarez FR, Wistuba II, Diao L, Chen F, Sachdeva M, Wang J, Kirsch DG, Creighton CJ, Gibbons DL. Kundu ST, et al. Among authors: rodriguez bl. Genes Dev. 2022 May 1;36(9-10):582-600. doi: 10.1101/gad.349321.121. Epub 2022 Jun 2. Genes Dev. 2022. PMID: 35654454 Free PMC article.

7

MEK inhibition invigorates chemoimmunotherapy by tumor mitophagy-induced CXCL10 expression.

Rodriguez BL, Gibbons DL. Rodriguez BL, et al. Cell Rep Med. 2022 Jan 18;3(1):100506. doi: 10.1016/j.xcrm.2021.100506. eCollection 2022 Jan 18. Cell Rep Med. 2022. PMID: 35106515 Free PMC article.

8

Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer.

Padhye A, Konen JM, Rodriguez BL, Fradette JJ, Ochieng JK, Diao L, Wang J, Lu W, Solis LS, Batra H, Raso MG, Peoples MD, Minelli R, Carugo A, Bristow CA, Gibbons DL. Padhye A, et al. Among authors: rodriguez bl. JCI Insight. 2021 Sep 8;6(17):e148392. doi: 10.1172/jci.insight.148392. JCI Insight. 2021. PMID: 34309585 Free PMC article.

9

p53 loss activates prometastatic secretory vesicle biogenesis in the Golgi.

Tan X, Banerjee P, Shi L, Xiao GY, Rodriguez BL, Grzeskowiak CL, Liu X, Yu J, Gibbons DL, Russell WK, Creighton CJ, Kurie JM. Tan X, et al. Among authors: rodriguez bl. Sci Adv. 2021 Jun 18;7(25):eabf4885. doi: 10.1126/sciadv.abf4885. Print 2021 Jun. Sci Adv. 2021. PMID: 34144984 Free PMC article.

10

Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers.

Peng DH, Rodriguez BL, Diao L, Gaudreau PO, Padhye A, Konen JM, Ochieng JK, Class CA, Fradette JJ, Gibson L, Chen L, Wang J, Byers LA, Gibbons DL. Peng DH, et al. Among authors: rodriguez bl. Nat Commun. 2021 May 10;12(1):2606. doi: 10.1038/s41467-021-22875-w. Nat Commun. 2021. PMID: 33972557 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year